Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:06:04 EDT Thu 20 Mar 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:QTRX - QUANTERIX CORPORATION - https://www.quanterix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
QTRX - Q0.16.30·8.350.17.24+0.040.61,044.77,2646,7457.09  7.45  6.9625.52  6.3017:34:36Mar 1915 min RT 2¢

Recent Trades - Last 10 of 6745
Time ETExPriceChangeVolume
17:34:36Q7.240.0453,100
16:05:11Q7.240.041
16:05:08Q7.240.041
16:01:49Q7.240.04215
16:01:14Q7.240.04507
16:00:04Q7.240.043
16:00:04Q7.240.042,160
16:00:04Q7.240.04927
16:00:04Q7.240.0486
16:00:04Q7.240.0472

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-03-19 16:10U:QTRXNews ReleaseSERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
2025-03-17 16:01U:QTRXNews ReleaseQuanterix Releases Financial Results for the Fourth Quarter of 2024
2025-03-17 16:00U:QTRXNews ReleaseKent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call
2025-03-17 16:00U:QTRXNews ReleaseAkoya Reports Fourth Quarter of 2024 and Full Year Financial Results
2025-03-13 13:00U:QTRXNews ReleaseQuanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
2025-03-11 08:00U:QTRXNews ReleaseKent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences
2025-03-03 08:00U:QTRXNews ReleaseKent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board
2025-03-03 06:00U:QTRXNews ReleaseQuanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
2025-02-18 15:40U:QTRXNews ReleaseKent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences
2025-02-04 16:15U:QTRXNews ReleaseINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix Corporation - QTRX
2025-01-14 07:00U:QTRXNews ReleaseQuanterix Provides Update on Financial Performance
2025-01-10 07:00U:QTRXNews ReleaseQuanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
2025-01-06 09:30U:QTRXNews ReleaseDavid R. Walt Receives National Medal of Technology and Innovation
2025-01-02 16:26U:QTRXNews ReleaseQuanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-12-17 06:59U:QTRXNews ReleaseQuanterix Expands Capabilities with Strategic Acquisition of EMISSION
2024-11-22 17:00U:QTRXNews ReleaseQuanterix Announces Receipt of Expected Notice from Nasdaq
2024-11-12 16:01U:QTRXNews ReleaseQuanterix Releases Preliminary Financial Results for the Third Quarter of 2024
2024-11-05 16:00U:QTRXNews ReleaseQuanterix To Report Third Quarter 2024 Financial Results on November 12, 2024
2024-10-28 16:30U:QTRXNews ReleaseNew Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information
2024-10-02 16:00U:QTRXNews ReleaseQuanterix Welcomes Ivana Magovcevic-Liebisch, Ph.D., J.D. to Board of Directors